Company disclosures
AMIX Hit $3.30 and Closed Up Just 9%. Its Filing Shows Where the Cash Came From.
Public sources checked through November 11, 2026, at 5:54 p.m. ET.
Autonomix Medical traded as high as $3.30 on Nov. 10, about 94% above its prior $1.70 close. It finished at $1.85, up 8.82%, on about 72.18 million shares. The company’s 10-Q, filed that day, reported $7.7 million in cash at September end. Its cash-flow statement showed roughly $7.5 million in gross warrant exercise proceeds over the preceding six months, while operations used about $6.2 million. A direct trigger for the intraday spike was not verified. Nov. 10 third-party daily prices · Same-day 10-Q
The net loss shrank faster than the cash burn
In the quarter ended Sept. 30, the net loss narrowed from about $7.5 million a year earlier to $3.1 million. Both quarters had zero revenue. The company attributed much of the reduction in research and administrative costs to lower stock compensation after option cancellations. Over the six months ended the same date, operations used about $6.2 million in cash, compared with $6.4 million a year earlier. The improvement in reported loss was much larger than the improvement in operating cash use. 10-Q results discussion and cash-flow statement
Cash from the old warrants and potential shares from the new ones
The warrant proceeds came from exercises in July and August. Under an Aug. 24 inducement agreement, the holder agreed to exercise warrants for 857,462 shares at $5.75 each. The company reported roughly $4.9 million in gross proceeds and issued new Series E warrants in the transaction. The filing published Nov. 10 records the cash under financing activities. The new warrants created a separate source of potential future issuance. 10-Q August warrant and financing disclosures
Including about $300,000 in net proceeds from October’s at-the-market sales, management estimated that cash could fund operations into the second calendar quarter of 2027, with no runway beyond that quarter under its estimate. Nov. 10 10-Q liquidity discussion
This article explains common concepts; examples are not trading recommendations.